Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

ClinicalTrials.gov ID: NCT00318500

Public ClinicalTrials.gov record NCT00318500. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 75 mg and 150 mg Doses of ERB-041 on the Reduction of Symptoms Associated With Endometriosis During Treatment and Post Treatment in Reproductive-Aged Women

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the efficacy and safety of two doses of ERB-041 (75 mg and 150 mg) relative to placebo on the relief of endometriosis-related symptoms (dysmenorrhea, pelvic pain, and deep dyspareunia) in reproductive aged women.

Study identification

NCT ID
NCT00318500
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2006 (Type not available)
Primary completion
Not listed
Completion
Dec 2006 (Actual)
Last update posted
Dec 10, 2007

2006

United States locations

U.S. sites
49
U.S. states
24
U.S. cities
44
Facility City State ZIP Site status
Not listed Montgomery Alabama 36116 —
Not listed Chandler Arizona 85225 —
Not listed Phoenix Arizona 85032 —
Not listed Phoenix Arizona 85035 —
Not listed Tucson Arizona 85712 —
Not listed San Francisco California 94115 —
Not listed Vista California 92083 —
Not listed Denver Colorado 80202 —
Not listed Denver Colorado 80206 —
Not listed New Britain Connecticut 06050 —
Not listed Clearwater Florida 33759 —
Not listed New Port Richey Florida 34652 —
Not listed Plantation Florida 33324 —
Not listed Venice Florida 34285 —
Not listed West Palm Beach Florida 33401 —
Not listed West Palm Beach Florida 33409 —
Not listed Marietta Georgia 30066 —
Not listed Idaho Falls Idaho 83404 —
Not listed Oak Brook Illinois 60523 —
Not listed Evansville Indiana 47714 —
Not listed Reno Nevada 89502 —
Not listed Lawrenceville New Jersey 08648 —
Not listed Durham North Carolina 27710 —
Not listed New Bern North Carolina 28562 —
Not listed Raleigh North Carolina 27612 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Cleveland Ohio 44122 —
Not listed Miamisburg Ohio 45342 —
Not listed Oklahoma City Oklahoma 73112 —
Not listed Portland Oregon 97210 —
Not listed Abington Pennsylvania 19001 —
Not listed Lansdale Pennsylvania 19446 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed Philadelphia Pennsylvania 19114 —
Not listed Pittsburgh Pennsylvania 15243 —
Not listed Columbia South Carolina 29201 —
Not listed Greenville South Carolina 29607 —
Not listed Bristol Tennessee 37620 —
Not listed Chattanooga Tennessee 37403 —
Not listed Memphis Tennessee 38119 —
Not listed Corpus Christi Texas 78414 —
Not listed San Antonio Texas 78229 —
Not listed West Valley City Utah 84120 —
Not listed Norfolk Virginia 23507 —
Not listed Richmond Virginia 23233 —
Not listed Richmond Virginia 23294 —
Not listed Virginia Beach Virginia 23456 —
Not listed Renton Washington 98055 —
Not listed Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00318500, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2007 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00318500 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →